Gritstone bio Inc expected to post a loss of 41 cents a share - Earnings Preview

Gritstone bio

28/10/2022 13:26

* Gritstone bio Inc  GRTS.OQ   GRTS.O  is expected to show a
rise
in quarterly revenue when it reports  results on November 1
(estimated). 
    * The Emeryville California-based  company is expected to
report 
a 24.7% increase in revenue to $3.26 million from $2.61 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Gritstone bio Inc
is for
a loss of 41 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Gritstone
bio Inc
is $11.99​, above​ its last closing price of $2.41. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.39       -0.40      -0.34     Beat    14.1
 Mar. 31 2022  -0.35       -0.37      -0.34     Beat    7.5
 Dec. 31 2021  -0.34       -0.38      -0.37     Beat    3.3​
 Sep. 30 2021  -0.49       -0.52      -0.36     Beat    30.6
 ​​Jun.        -0.58       -0.58      -0.33     Beat    42.8
 30 2021                                                
 Mar. 31 2021  -0.31       -0.39      0.10      Beat    125.6​
 Dec. 31 2020  -0.59       -0.61      -0.69     Missed  -12.7
 Sep. 30 2020  -0.64       -0.64      -0.69     Missed  -7.5
 This summary was machine generated October 28 at 12:26 GMT.  All
figures in US dollars  unless otherwise stated